Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Pregnancy and Medication Impact, and HIV Research and Treatment.
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
An Open Label, Randomized, Multicenter Study of Elafibranor in Children With Nonalcoholic Steatohepatitis
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Pharmacokinetics of tenofovir during pregnancy and postpartum
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Obstetric Pharmacokinetic Dosing Studies are Urgently Needed
Raltegravir Pharmacokinetics During Pregnancy
Protecting the Fetus Against HIV Infection: A Systematic Review of Placental Transfer of Antiretrovirals
Variability in Metabolism of Imipramine and Desipramine Using Urinary Excretion Data†
Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder